TrialDrug design, development and therapy2015

Phase II trial of docetaxel combined with nedaplatin for patients with recurrent and metastatic nasopharyngeal carcinoma.

Pei-Jian Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.